-
公开(公告)号:SK125199A3
公开(公告)日:2000-08-14
申请号:SK125199
申请日:1998-03-09
Applicant: BASF AG
Inventor: BARLOZZARI TERESA , HAUPT ANDREAS
IPC: A61K31/337 , A61K38/07 , A61K38/08 , A61K38/00 , A61K38/15 , A61P35/00 , C07K5/08 , C07K5/10 , C07K7/00 , A61K38/04
Abstract: The present invention provides compositions and methods for the treatment of cancer in a subject wherein compounds of Formula I as defined herein in combination with paclitaxel, taxotere or modified taxane or taxoid analogs provide enhanced anticancer effects over the effects achieved with the individual compounds.
-
公开(公告)号:TR200000132T2
公开(公告)日:2000-05-22
申请号:TR200000132
申请日:1998-07-07
Applicant: BASF AG
Inventor: JANSSEN BERND , BARLOZZARI TERESA , HAUPT ANDREAS , ZIERKE THOMAS , KLING ANDREAS
Abstract: Compounds of the present invention include cell growth inhibitors which are peptides of Formula I, A-B-D-E-F-(G)r-(K)s-L (I), and acid salts thereof, wherein A, B, D, E, F, G and K are α-amino acid residues, and s and r are each, independently, 0 or 1. L is a monovalent radical, such as, for example, an amino group, an N-substituted amino group, a &bgr;-hydroxylamino group, a hydrazido group, an alkoxy group, a thioalkoxy group, an aminoxy group, or an oximato group. The present invention also includes a method for treating cancer in a mammal, such as a human, comprising administering to the mammal an effective amount of a compound of Formula I in a pharmaceutically acceptable composition.
-
公开(公告)号:CZ321399A3
公开(公告)日:2000-04-12
申请号:CZ321399
申请日:1998-03-05
Applicant: BASF AG
Inventor: RITTER KURT , AMBERG WILHELM , BARLOZZARI TERESA , HAUPT ANDREAS , JANNSEN BERN , KLING ANDREAS
-
公开(公告)号:NO20001758D0
公开(公告)日:2000-04-05
申请号:NO20001758
申请日:2000-04-05
Applicant: BASF AG
Inventor: BARLOZZARI TERESA , BANERJEE SUBHASHIS , HAUPT ANDREAS
Abstract: The present invention provides compositions and methods for the treatment of rheumatoid arthritis in a subject wherein one or more compounds of Formula I as defined herein alone or in combination with one or more other antiarthritic drugs provide suppression of rheumatoid arthritis.
-
公开(公告)号:BR9808017A
公开(公告)日:2000-03-08
申请号:BR9808017
申请日:1998-03-05
Applicant: BASF AG
Inventor: RITTER KURT , AMBERG WILHELM , BARLOZZARI TERESA , HAUPT ANDREAS , JANSSEN BERND , KLING ANDREAS
Abstract: The present invention relates to novel peptides useful as anti-cancer agents. The compounds of the invention are of Formula I,A-B-D-E-F-G(I)A, B, D, and E are alpha -amino acid residues. In one embodiment, F is an azacycloalkanecarboxylic acid residue. In this embodiment, G is a monovalent radical, for example, a hydrogen atom, an alkyl group, an aryl group, or a heteroaryl group. In another embodiment, F is an azacycloalkyl group and G is a heteroaryl group connected to F by a carbon-carbon bond. In another embodiment, the invention includes a method for treating cancer in a mammal, such as a human, comprising administering to the mammal an effective amount of a compound of Formula I in a pharmaceutically acceptable composition.
-
公开(公告)号:CZ321199A3
公开(公告)日:2000-02-16
申请号:CZ321199
申请日:1998-03-09
Applicant: BASF AG
Inventor: BARLOZZARI TERESA , HAUPT ANDREAS
IPC: A61K38/00 , A61K31/337 , A61K38/07 , A61K38/08 , A61K38/15 , A61P35/00 , C07K5/08 , C07K5/10 , C07K7/00 , A61K38/04
Abstract: The present invention provides compositions and methods for the treatment of cancer in a subject wherein compounds of Formula I as defined herein in combination with paclitaxel, taxotere or modified taxane or taxoid analogs provide enhanced anticancer effects over the effects achieved with the individual compounds.
-
公开(公告)号:ZA986358B
公开(公告)日:2000-01-17
申请号:ZA986358
申请日:1998-07-17
Applicant: BASF AG
Inventor: JANSSEN BERND , BARLOZZARI TERESA , HAUPT ANDREAS , ZIERKE THOMAS , KLING ANDREAS
Abstract: Compounds of the present invention include cell growth inhibitors which are peptides of Formula I, A-B-D-E-F-(G)r-(K)s-L (I), and acid salts thereof, wherein A, B, D, E, F, G and K are α-amino acid residues, and s and r are each, independently, 0 or 1. L is a monovalent radical, such as, for example, an amino group, an N-substituted amino group, a &bgr;-hydroxylamino group, a hydrazido group, an alkoxy group, a thioalkoxy group, an aminoxy group, or an oximato group. The present invention also includes a method for treating cancer in a mammal, such as a human, comprising administering to the mammal an effective amount of a compound of Formula I in a pharmaceutically acceptable composition.
-
公开(公告)号:AU9603998A
公开(公告)日:1999-04-27
申请号:AU9603998
申请日:1998-10-06
Applicant: BASF AG
Inventor: ARNOLD LEE D , XU YAJUN , BARLOZZARI TERESA , RAFFERTY PAUL , HOCKLEY MICHAEL , TURNER ALLYSON
IPC: A61K31/415
-
公开(公告)号:AU9502498A
公开(公告)日:1999-04-27
申请号:AU9502498
申请日:1998-09-24
Applicant: BASF AG
Inventor: BARLOZZARI TERESA , BANERJEE SUBHASHIS , HAUPT ANDREAS
Abstract: The present invention provides compositions and methods for the treatment of rheumatoid arthritis in a subject wherein one or more compounds of Formula I as defined herein alone or in combination with one or more other antiarthritic drugs provide suppression of rheumatoid arthritis.
-
公开(公告)号:CA2304565A1
公开(公告)日:1999-04-15
申请号:CA2304565
申请日:1998-10-06
Applicant: BASF AG
Inventor: ARNOLD LEE D , BARLOZZARI TERESA , XU YAJUN
IPC: A61K31/416 , A61K31/4427 , A61K31/443 , A61K31/4433 , A61K31/4439 , A61P1/04 , A61P3/10 , A61P9/00 , A61P9/10 , A61P17/02 , A61P17/06 , A61P19/02 , A61P19/08 , A61P27/00 , A61P35/00 , A61P43/00 , C07D231/54 , C07D231/56 , C07D401/04 , C07D405/04 , C07D409/04 , A61K31/415 , A61K31/44
Abstract: Chemical compounds that are derivatives of indeno1,2-c!-, naphtho1,2-c!- and benzo6,7!cyclohepta1,2-c!pyrazole are inhibitors of tyrosine kinase activity. Several of the tyrosine kinases, whose activity is inhibited by these chemical compounds, are involved in hyperproliferative, angiogenic or in vascular hyperpermeability processes. Thus, these chemical compounds can ameliorate disease states where tumor formation, metastasis, angiogenesis, vascular hyperpermeability or endothelial cell proliferation is a factor.
-
-
-
-
-
-
-
-
-